ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 162 filers reported holding ACORDA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,655,000 | +702.1% | 641,178 | -0.3% | 0.01% | +400.0% |
| Q3 2020 | $331,000 | -31.9% | 643,258 | -2.7% | 0.00% | 0.0% |
| Q2 2020 | $486,000 | +14.4% | 661,132 | +45.0% | 0.00% | 0.0% |
| Q1 2020 | $425,000 | -37.6% | 455,905 | +36.6% | 0.00% | -50.0% |
| Q4 2019 | $681,000 | -2.4% | 333,794 | +37.3% | 0.00% | 0.0% |
| Q3 2019 | $698,000 | -58.2% | 243,168 | +11.7% | 0.00% | -50.0% |
| Q2 2019 | $1,670,000 | -35.9% | 217,714 | +11.1% | 0.00% | -33.3% |
| Q1 2019 | $2,604,000 | +451.7% | 195,942 | +546.8% | 0.01% | +500.0% |
| Q4 2018 | $472,000 | +23500.0% | 30,293 | +33558.9% | 0.00% | – |
| Q3 2018 | $2,000 | -92.3% | 90 | -91.8% | 0.00% | – |
| Q3 2017 | $26,000 | -3.7% | 1,100 | -18.6% | 0.00% | – |
| Q2 2017 | $27,000 | 0.0% | 1,351 | +5.7% | 0.00% | – |
| Q1 2017 | $27,000 | +1250.0% | 1,278 | +1477.8% | 0.00% | – |
| Q4 2016 | $2,000 | 0.0% | 81 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 81 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 81 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -99.8% | 81 | -99.7% | 0.00% | -100.0% |
| Q4 2015 | $1,055,000 | +32.7% | 24,663 | -17.8% | 0.00% | 0.0% |
| Q3 2015 | $795,000 | -20.5% | 30,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $1,000,000 | +50.2% | 30,000 | +50.0% | 0.00% | +50.0% |
| Q1 2015 | $666,000 | +25.2% | 20,000 | +53.8% | 0.00% | 0.0% |
| Q4 2014 | $532,000 | +107.0% | 13,000 | +71.1% | 0.00% | +100.0% |
| Q3 2014 | $257,000 | -21.4% | 7,600 | -21.6% | 0.00% | 0.0% |
| Q2 2014 | $327,000 | +26.7% | 9,700 | +42.6% | 0.00% | 0.0% |
| Q1 2014 | $258,000 | +29.6% | 6,800 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $199,000 | -14.6% | 6,800 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $233,000 | -22.1% | 6,800 | -25.1% | 0.00% | 0.0% |
| Q2 2013 | $299,000 | – | 9,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |